nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—SLC1A1—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0491	0.107	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0316	0.0692	CbGpPWpGaD
Pregabalin—SLC1A1—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0308	0.0675	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0289	0.0633	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0289	0.0633	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0219	0.048	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.0204	0.0446	CbGpPWpGaD
Pregabalin—SLC1A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0182	0.0397	CbGpPWpGaD
Pregabalin—Henoch-Schonlein purpura—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0321	CcSEcCtD
Pregabalin—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0321	CcSEcCtD
Pregabalin—Sialoadenitis—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0299	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0141	0.0309	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0136	0.0297	CbGpPWpGaD
Pregabalin—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0255	CcSEcCtD
Pregabalin—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0255	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0129	0.0283	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0129	0.0283	CbGpPWpGaD
Pregabalin—CACNA1A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0112	0.0246	CbGpPWpGaD
Pregabalin—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0209	CcSEcCtD
Pregabalin—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0209	CcSEcCtD
Pregabalin—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.00979	0.0188	CcSEcCtD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00979	0.0214	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00979	0.0214	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00941	0.0206	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0091	0.0199	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0091	0.0199	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00883	0.0193	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00811	0.0178	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00805	0.0176	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00805	0.0176	CbGpPWpGaD
Pregabalin—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0149	CcSEcCtD
Pregabalin—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0149	CcSEcCtD
Pregabalin—CACNA2D2—Integration of energy metabolism—CHRM3—nephrolithiasis	0.0074	0.0162	CbGpPWpGaD
Pregabalin—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.00722	0.0139	CcSEcCtD
Pregabalin—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00722	0.0139	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00718	0.0157	CbGpPWpGaD
Pregabalin—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00677	0.013	CcSEcCtD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00662	0.0145	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00656	0.0144	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00656	0.0144	CbGpPWpGaD
Pregabalin—SLC1A1—nephron tubule—nephrolithiasis	0.00628	0.274	CbGeAlD
Pregabalin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00591	0.0114	CcSEcCtD
Pregabalin—SLC1A1—renal system—nephrolithiasis	0.00571	0.249	CbGeAlD
Pregabalin—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0109	CcSEcCtD
Pregabalin—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00552	0.0106	CcSEcCtD
Pregabalin—SLC1A1—kidney—nephrolithiasis	0.00552	0.241	CbGeAlD
Pregabalin—SLC1A1—cortex of kidney—nephrolithiasis	0.00537	0.235	CbGeAlD
Pregabalin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00527	0.0101	CcSEcCtD
Pregabalin—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00986	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00497	0.0109	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00497	0.0109	CbGpPWpGaD
Pregabalin—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00953	CcSEcCtD
Pregabalin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00484	0.0093	CcSEcCtD
Pregabalin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00901	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00462	0.0101	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00462	0.0101	CbGpPWpGaD
Pregabalin—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00887	CcSEcCtD
Pregabalin—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00432	0.0083	CcSEcCtD
Pregabalin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00825	CcSEcCtD
Pregabalin—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00813	CcSEcCtD
Pregabalin—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00808	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00412	0.00903	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00412	0.00903	CbGpPWpGaD
Pregabalin—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00786	CcSEcCtD
Pregabalin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00786	CcSEcCtD
Pregabalin—Gout—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00781	CcSEcCtD
Pregabalin—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00771	CcSEcCtD
Pregabalin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00762	CcSEcCtD
Pregabalin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00748	CcSEcCtD
Pregabalin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00387	0.00743	CcSEcCtD
Pregabalin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00387	0.00743	CcSEcCtD
Pregabalin—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0038	0.0073	CcSEcCtD
Pregabalin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00717	CcSEcCtD
Pregabalin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00689	CcSEcCtD
Pregabalin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00667	CcSEcCtD
Pregabalin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00343	0.0066	CcSEcCtD
Pregabalin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00343	0.0066	CcSEcCtD
Pregabalin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00649	CcSEcCtD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0033	0.00722	CbGpPWpGaD
Pregabalin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00612	CcSEcCtD
Pregabalin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00609	CcSEcCtD
Pregabalin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00603	CcSEcCtD
Pregabalin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00598	CcSEcCtD
Pregabalin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00592	CcSEcCtD
Pregabalin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00581	CcSEcCtD
Pregabalin—Injury—Hydrochlorothiazide—nephrolithiasis	0.003	0.00576	CcSEcCtD
Pregabalin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00571	CcSEcCtD
Pregabalin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00566	CcSEcCtD
Pregabalin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00564	CcSEcCtD
Pregabalin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00561	CcSEcCtD
Pregabalin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00561	CcSEcCtD
Pregabalin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00291	0.00559	CcSEcCtD
Pregabalin—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00291	0.00559	CcSEcCtD
Pregabalin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00556	CcSEcCtD
Pregabalin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00556	CcSEcCtD
Pregabalin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00549	CcSEcCtD
Pregabalin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00545	CcSEcCtD
Pregabalin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00532	CcSEcCtD
Pregabalin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00276	0.0053	CcSEcCtD
Pregabalin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00276	0.0053	CcSEcCtD
Pregabalin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00525	CcSEcCtD
Pregabalin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00521	CcSEcCtD
Pregabalin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00521	CcSEcCtD
Pregabalin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00511	CcSEcCtD
Pregabalin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00502	CcSEcCtD
Pregabalin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00498	CcSEcCtD
Pregabalin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00496	CcSEcCtD
Pregabalin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00489	CcSEcCtD
Pregabalin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00485	CcSEcCtD
Pregabalin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00484	CcSEcCtD
Pregabalin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00482	CcSEcCtD
Pregabalin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00479	CcSEcCtD
Pregabalin—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00477	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00477	CcSEcCtD
Pregabalin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00469	CcSEcCtD
Pregabalin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00467	CcSEcCtD
Pregabalin—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00467	CcSEcCtD
Pregabalin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00461	CcSEcCtD
Pregabalin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00458	CcSEcCtD
Pregabalin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00458	CcSEcCtD
Pregabalin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00449	CcSEcCtD
Pregabalin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00446	CcSEcCtD
Pregabalin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00428	CcSEcCtD
Pregabalin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00428	CcSEcCtD
Pregabalin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00423	CcSEcCtD
Pregabalin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00219	0.00422	CcSEcCtD
Pregabalin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00418	CcSEcCtD
Pregabalin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00417	CcSEcCtD
Pregabalin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00215	0.00413	CcSEcCtD
Pregabalin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00411	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00405	CcSEcCtD
Pregabalin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00402	CcSEcCtD
Pregabalin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00401	CcSEcCtD
Pregabalin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00208	0.004	CcSEcCtD
Pregabalin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00208	0.004	CcSEcCtD
Pregabalin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00398	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—GRHPR—nephrolithiasis	0.00207	0.00452	CbGpPWpGaD
Pregabalin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00397	CcSEcCtD
Pregabalin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00397	CcSEcCtD
Pregabalin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00391	CcSEcCtD
Pregabalin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00389	CcSEcCtD
Pregabalin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.002	0.00385	CcSEcCtD
Pregabalin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00383	CcSEcCtD
Pregabalin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00373	CcSEcCtD
Pregabalin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00367	CcSEcCtD
Pregabalin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00366	CcSEcCtD
Pregabalin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00365	CcSEcCtD
Pregabalin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00364	CcSEcCtD
Pregabalin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00361	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—AGXT—nephrolithiasis	0.00184	0.00403	CbGpPWpGaD
Pregabalin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00353	CcSEcCtD
Pregabalin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00346	CcSEcCtD
Pregabalin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00342	CcSEcCtD
Pregabalin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00177	0.0034	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—GRHPR—nephrolithiasis	0.00173	0.00379	CbGpPWpGaD
Pregabalin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00327	CcSEcCtD
Pregabalin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00324	CcSEcCtD
Pregabalin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00314	CcSEcCtD
Pregabalin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00313	CcSEcCtD
Pregabalin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00312	CcSEcCtD
Pregabalin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0031	CcSEcCtD
Pregabalin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00309	CcSEcCtD
Pregabalin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00307	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—APRT—nephrolithiasis	0.00157	0.00343	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC26A1—nephrolithiasis	0.00157	0.00343	CbGpPWpGaD
Pregabalin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00301	CcSEcCtD
Pregabalin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00299	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—AGXT—nephrolithiasis	0.00154	0.00338	CbGpPWpGaD
Pregabalin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00296	CcSEcCtD
Pregabalin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00295	CcSEcCtD
Pregabalin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00293	CcSEcCtD
Pregabalin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00291	CcSEcCtD
Pregabalin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00288	CcSEcCtD
Pregabalin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00287	CcSEcCtD
Pregabalin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00286	CcSEcCtD
Pregabalin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00285	CcSEcCtD
Pregabalin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00282	CcSEcCtD
Pregabalin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00146	0.0028	CcSEcCtD
Pregabalin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00278	CcSEcCtD
Pregabalin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00272	CcSEcCtD
Pregabalin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00272	CcSEcCtD
Pregabalin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00272	CcSEcCtD
Pregabalin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00271	CcSEcCtD
Pregabalin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00268	CcSEcCtD
Pregabalin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00138	0.00266	CcSEcCtD
Pregabalin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00262	CcSEcCtD
Pregabalin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0026	CcSEcCtD
Pregabalin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0026	CcSEcCtD
Pregabalin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00133	0.00256	CcSEcCtD
Pregabalin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00133	0.00255	CcSEcCtD
Pregabalin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00132	0.00254	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—SLC26A1—nephrolithiasis	0.00131	0.00287	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—APRT—nephrolithiasis	0.00131	0.00287	CbGpPWpGaD
Pregabalin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00252	CcSEcCtD
Pregabalin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00129	0.00248	CcSEcCtD
Pregabalin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00243	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00237	CcSEcCtD
Pregabalin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00235	CcSEcCtD
Pregabalin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00122	0.00234	CcSEcCtD
Pregabalin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00121	0.00232	CcSEcCtD
Pregabalin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0012	0.00231	CcSEcCtD
Pregabalin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00226	CcSEcCtD
Pregabalin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00117	0.00224	CcSEcCtD
Pregabalin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00223	CcSEcCtD
Pregabalin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00223	CcSEcCtD
Pregabalin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00215	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—AQP1—nephrolithiasis	0.00112	0.00244	CbGpPWpGaD
Pregabalin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00213	CcSEcCtD
Pregabalin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00207	CcSEcCtD
Pregabalin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00206	CcSEcCtD
Pregabalin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00206	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—CHRM3—nephrolithiasis	0.00101	0.00221	CbGpPWpGaD
Pregabalin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000998	0.00192	CcSEcCtD
Pregabalin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000972	0.00187	CcSEcCtD
Pregabalin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000958	0.00184	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—AQP1—nephrolithiasis	0.000935	0.00205	CbGpPWpGaD
Pregabalin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000927	0.00178	CcSEcCtD
Pregabalin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000896	0.00172	CcSEcCtD
Pregabalin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000861	0.00166	CcSEcCtD
Pregabalin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000854	0.00164	CcSEcCtD
Pregabalin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000853	0.00164	CcSEcCtD
Pregabalin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000849	0.00163	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—CHRM3—nephrolithiasis	0.000846	0.00185	CbGpPWpGaD
Pregabalin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000805	0.00155	CcSEcCtD
